| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679867 | Alzheimer's & Dementia | 2018 | 8 Pages |
Abstract
Most persons with preclinical AD will not develop AD dementia during their lifetimes. Lifetime risks help interpret the clinical significance of biomarker screening tests for AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ron Brookmeyer, Nada Abdalla,